Biologics Market Report 2026
Download Free Sample Buy Now
Biologics Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 400

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Biologics Market Report 2026

Global Outlook – By Type (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines), By Drug Classification (Branded Drugs, Generic Drugs), By Route Of Administration (Oral, Other Route Of Administration), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other Distribution Channels) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Biologics Market Overview

• Biologics market size has reached to $495.56 billion in 2025

• Expected to grow to $827.24 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%

• Growth Driver: Personalized Medicine Fueling Growth In The Biologics Market

• Market Trend: Advancing Efficiency Through Next-Generation Biomanufacturing

• North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Biologics Market?

Biologics are medications made from organic materials that can be used to treat a wide range of illnesses, and they are frequently used to treat immune-related illnesses. The interesting aspect is that biologics are separated from various natural sources, whether they be carbohydrates, proteins, nucleic acids, or a complex mixture of these materials.

The main types of biologics are monoclonal antibodies (MAbs), therapeutic proteins, and vaccines. Monoclonal antibodies, or mAbs, are created in a laboratory to combat a specific infection. The various routes of administration include oral, parenteral, and others that are distributed by hospital pharmacies, retail pharmacies or drug stores, and others.

Biologics Market Global Report 2026 Market Report bar graph

What Is The Biologics Market Size and Share 2026?

The biologics market size has grown strongly in recent years. It will grow from $495.56 billion in 2025 to $540.46 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to limited biologics availability, reliance on traditional therapies, growing prevalence of immune-related disorders, increasing healthcare infrastructure, rising physician awareness and prescriptions.

What Is The Biologics Market Growth Forecast?

The biologics market size is expected to see rapid growth in the next few years. It will grow to $827.24 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to development of novel monoclonal antibodies, expansion of mRNA and viral vector vaccines, increasing adoption of personalized biologic therapies, growing government support and funding for biologics, integration of digital health and patient monitoring platforms. Major trends in the forecast period include rising adoption of monoclonal antibodies and therapeutic proteins, growth in vaccine development including mrna and viral vector vaccines, expansion of prescription-based biologics and hospital pharmacy distribution, increasing focus on personalized medicine and targeted biologic therapies, integration of biologics with advanced healthcare solutions and patient monitoring.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Biologics Market Segmentation

1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines

2) By Drug Classification: Branded Drugs, Generic Drugs

3) By Route Of Administration: Oral, Other Route Of Administration

4) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other Distribution Channels

Subsegments:

1) By Monoclonal Antibodies (MAbs): Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies

2) By Therapeutic Proteins: Hormones, Enzymes, Cytokines, Fusion Proteins

3) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, mRNA Vaccines, Viral Vector Vaccines

What Is The Driver Of The Biologics Market?

The increasing demand for personalized medicine is driving significant growth in the global biologics market. Personalized medicine, also known as precision medicine, is a medical approach that tailors healthcare and medical treatment to the individual characteristics of each patient. Personalized medicine offers the ability to customize biological treatments to a patient's specific genetic and clinical profile transforming the healthcare landscape. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the biologics industry going forward.

Key Players In The Global Biologics Market

Major companies operating in the biologics market are Merck & Co. Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc., Bristol Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Amgen Inc., Shanghai Fosun Pharmaceuticals, Bayer AG, Novartis AG, BiosanaPharma, WuXi, Teva UK Limited, AstraZeneca, Abbott Laboratories, Vectura Group, Fujifilm, Lonza, Seqens, Piramal Pharma Solutions, Corden Pharma, Procos SpA and BSP Pharmaceuticals., Microgen, Geropharm, Valenta, NovaMedica, SynBi, Rani Therapeutics, Enteris BioPharma, Allena Pharmaceuticals, Biogen Inc., Emisphere Technologies Inc., Apotex, Gilead Sciences

Global Biologics Market Trends and Insights

Major companies operating in the biologics market are focusing on developing innovative products such as biosimilars to provide cost-effective alternatives to original biologic therapies. Biosimilars are biologic products highly similar to an already approved reference biologic, with no significant differences in safety, efficacy, or quality, helping reduce treatment costs and increase patient access to advanced therapies. For instance, in July 2025, Biocon Biologics, a subsidiary of Biocon Limited, an India-based biopharmaceutical company, launched Nepexto, a biosimilar to Enbrel (etanercept), in Australia. Nepexto is a fusion-protein biologic designed to inhibit tumor necrosis factor-alpha (TNF-a), a key inflammatory mediator in autoimmune conditions. It is composed of recombinant DNA-derived protein that mimics the binding activity of the original etanercept molecule, delivering comparable efficacy and safety while making treatment more accessible. Its unique features include high biosimilarity backed by robust clinical data, regulatory approvals, and an established supply chain via its local partner Generic Health making it a strong option for long-term management of diseases such as rheumatoid arthritis, psoriasis, and ankylosing spondylitis.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Biologics Market?

In October 2025, Terumo Corporation, a Japan-based healthcare technology company, acquired the drug-product plant and quality-control laboratory operations of WuXi Biologics in Leverkusen, Germany for an undisclosed amount. With this acquisition, Terumo Corporation aims to expand its contract-development and manufacturing organization (CDMO) footprint in Europe, enhance its integrated services for injectable therapeutics, and improve global responsiveness for biopharmaceutical clients. WuXi Biologics GmbH is a Germany-based life-sciences company that specializes in providing biopharmaceutical contract development and manufacturing services for biologics and advanced therapies.

Regional Insights

North America was the largest region in the biologics market in 2025. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Biologics Market?

The biologics market consists of sales of tumor necrosis factor inhibitors, Interleukin inhibitors, B-cells inhibitors, and T-cells inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biologics Market Report 2026?

The biologics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biologics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Biologics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $540.46 billion
Revenue Forecast In 2035 $827.24 billion
Growth Rate CAGR of 9.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Drug Classification, Route Of Administration, Mode Of Purchase, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Merck & Co. Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc., Bristol Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Amgen Inc., Shanghai Fosun Pharmaceuticals, Bayer AG, Novartis AG, BiosanaPhar
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Biologics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Biologics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Biologics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Biologics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Monoclonal Antibodies And Therapeutic Proteins

4.2.2 Growth In Vaccine Development Including Mrna And Viral Vector Vaccines

4.2.3 Expansion Of Prescription-Based Biologics And Hospital Pharmacy Distribution

4.2.4 Increasing Focus On Personalized Medicine And Targeted Biologic Therapies

4.2.5 Integration Of Biologics With Advanced Healthcare Solutions And Patient Monitoring

5. Biologics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Retail Pharmacies

5.3 Biopharmaceutical Companies

5.4 Research Laboratories

5.5 Specialty Clinics

6. Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biologics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Biologics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Biologics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Biologics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biologics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biologics Market Segmentation

9.1. Global Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines

9.2. Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Branded Drugs, Generic Drugs

9.3. Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Other Route Of Administration

9.4. Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prescription-Based Drugs, Over-The-Counter Drugs

9.5. Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other Distribution Channels

9.6. Global Biologics Market, Sub-Segmentation Of Monoclonal Antibodies (MAbs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies

9.7. Global Biologics Market, Sub-Segmentation Of Therapeutic Proteins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hormones, Enzymes, Cytokines, Fusion Proteins

9.8. Global Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, mRNA Vaccines, Viral Vector Vaccines

10. Biologics Market Regional And Country Analysis

10.1. Global Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biologics Market

11.1. Asia-Pacific Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biologics Market

12.1. China Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biologics Market

13.1. India Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biologics Market

14.1. Japan Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biologics Market

15.1. Australia Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biologics Market

16.1. Indonesia Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biologics Market

17.1. South Korea Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Bangladesh Biologics Market

18.1. Bangladesh Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Thailand Biologics Market

19.1. Thailand Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Vietnam Biologics Market

20.1. Vietnam Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Malaysia Biologics Market

21.1. Malaysia Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Singapore Biologics Market

22.1. Singapore Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Philippines Biologics Market

23.1. Philippines Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Hong Kong Biologics Market

24.1. Hong Kong Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. New Zealand Biologics Market

25.1. New Zealand Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Taiwan Biologics Market

26.1. Taiwan Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Taiwan Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. South East Asia Biologics Market

27.1. South East Asia Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. South East Asia Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Western Europe Biologics Market

28.1. Western Europe Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. Western Europe Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. UK Biologics Market

29.1. UK Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Germany Biologics Market

30.1. Germany Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. France Biologics Market

31.1. France Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Italy Biologics Market

32.1. Italy Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Spain Biologics Market

33.1. Spain Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Austria Biologics Market

34.1. Austria Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Belgium Biologics Market

35.1. Belgium Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Denmark Biologics Market

36.1. Denmark Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

37. Finland Biologics Market

37.1. Finland Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

38. Ireland Biologics Market

38.1. Ireland Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

39. Netherlands Biologics Market

39.1. Netherlands Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

40. Norway Biologics Market

40.1. Norway Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

41. Portugal Biologics Market

41.1. Portugal Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Sweden Biologics Market

42.1. Sweden Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Switzerland Biologics Market

42.1. Switzerland Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

43. Eastern Europe Biologics Market

43.1. Eastern Europe Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

43.2. Eastern Europe Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

44. Russia Biologics Market

44.1. Russia Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

45. Czech Republic Biologics Market

45.1. Czech Republic Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

46. Poland Biologics Market

46.1. Poland Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

47. Romania Biologics Market

47.1. Romania Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

48. Ukraine Biologics Market

48.1. Ukraine Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

49. North America Biologics Market

49.1. North America Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

49.2. North America Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

50. USA Biologics Market

50.1. USA Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

50.2. USA Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

51. Canada Biologics Market

51.1. Canada Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

51.2. Canada Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

52. Mexico Biologics Market

52.1. Mexico Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

52.2. Mexico Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

53. South America Biologics Market

53.1. South America Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

53.2. South America Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

54. Brazil Biologics Market

54.1. Brazil Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

55. Chile Biologics Market

55.1. Chile Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

56. Argentina Biologics Market

56.1. Argentina Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

57. Colombia Biologics Market

57.1. Colombia Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

58. Peru Biologics Market

58.1. Peru Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

59. Middle East Biologics Market

59.1. Middle East Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

59.2. Middle East Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

60. Saudi Arabia Biologics Market

60.1. Saudi Arabia Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

61. Israel Biologics Market

61.1. Israel Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

62. Iran Biologics Market

62.1. Iran Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

63. Turkey Biologics Market

63.1. Turkey Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

64. United Arab Emirates Biologics Market

64.1. United Arab Emirates Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

65. Africa Biologics Market

65.1. Africa Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

65.2. Africa Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

66. Egypt Biologics Market

66.1. Egypt Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

67. Nigeria Biologics Market

67.1. Nigeria Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

68. South Africa Biologics Market

68.1. South Africa Biologics Market, Segmentation By Type, Segmentation By Drug Classification, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

69. Biologics Market Regulatory and Investment Landscape

70. Biologics Market Competitive Landscape And Company Profiles

70.1. Biologics Market Competitive Landscape And Market Share 2024

70.1.1. Top 10 Companies (Ranked by revenue/share)

70.2. Biologics Market - Company Scoring Matrix

70.2.1. Market Revenues

70.2.2. Product Innovation Score

70.2.3. Brand Recognition

70.3. Biologics Market Company Profiles

70.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

70.3.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

70.3.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

70.3.4. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

70.3.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

71. Biologics Market Other Major And Innovative Companies

Bristol Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Amgen Inc., Shanghai Fosun Pharmaceuticals, Bayer AG, Novartis AG, BiosanaPharma, WuXi, Teva UK Limited, AstraZeneca, Abbott Laboratories, Vectura Group, Fujifilm

72. Global Biologics Market Competitive Benchmarking And Dashboard

73. Key Mergers And Acquisitions In The Biologics Market

74. Biologics Market High Potential Countries, Segments and Strategies

74.1 Biologics Market In 2030 - Countries Offering Most New Opportunities

74.2 Biologics Market In 2030 - Segments Offering Most New Opportunities

74.3 Biologics Market In 2030 - Growth Strategies

74.3.1 Market Trend Based Strategies

74.3.2 Competitor Strategies

75. Appendix

75.1. Abbreviations

75.2. Currencies

75.3. Historic And Forecast Inflation Rates

75.4. Research Inquiries

75.5. The Business Research Company

75.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Biologics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Biologics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Biologics Market, Supply Chain Analysis
  • Table 4: Global Biologics Market, Major Raw Material Providers
  • Table 5: Global Biologics Market, Major Resource Providers
  • Table 6: Global Biologics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Biologics Market, Major Distributors And Channel Partners
  • Table 8: Global Biologics Market, Key Technologies & Future Trends
  • Table 9: Global Biologics Market, Major Trends
  • Table 10: Global Biologics Market, Major End Users
  • Table 11: Global Biologics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Biologics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Biologics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Biologics Market - TAM, US$ Billion, 2025
  • Table 15: Global Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Biologics Market, Sub-Segmentation Of Monoclonal Antibodies (MAbs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Biologics Market, Sub-Segmentation Of Therapeutic Proteins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Bangladesh, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Bangladesh, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Bangladesh, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Thailand, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Thailand, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Thailand, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Vietnam, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Vietnam, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Vietnam, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Malaysia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Malaysia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Malaysia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Singapore, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Singapore, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Singapore, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Philippines, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Philippines, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Philippines, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Hong Kong, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Hong Kong, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Hong Kong, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: New Zealand, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: New Zealand, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: New Zealand, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Taiwan, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Taiwan, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Taiwan, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: South East Asia , Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: South East Asia , Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: South East Asia , Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Western Europe, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Western Europe, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: Western Europe, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: UK, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: UK, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: UK, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Germany, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Germany, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Germany, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: France, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: France, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: France, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Italy, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Italy, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Italy, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Spain, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Spain, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Spain, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Austria, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Austria, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Austria, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Belgium, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Belgium, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Belgium, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 100: Denmark, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 101: Denmark, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 102: Denmark, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 103: Finland, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 104: Finland, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 105: Finland, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 106: Ireland, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 107: Ireland, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 108: Ireland, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 109: Netherlands, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 110: Netherlands, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 111: Netherlands, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 112: Norway, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 113: Norway, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 114: Norway, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 115: Portugal, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 116: Portugal, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 117: Portugal, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 118: Sweden, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 119: Sweden, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 120: Sweden, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 121: Switzerland, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 122: Switzerland, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 123: Switzerland, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 124: Eastern Europe, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 125: Eastern Europe, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 126: Eastern Europe, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 127: Russia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 128: Russia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 129: Russia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 130: Czech Republic, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 131: Czech Republic, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 132: Czech Republic, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 133: Poland, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 134: Poland, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 135: Poland, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 136: Romania, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 137: Romania, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 138: Romania, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 139: Ukraine, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 140: Ukraine, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 141: Ukraine, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 142: North America, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 143: North America, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 144: North America, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 145: USA, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 146: USA, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 147: USA, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 148: Canada, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 149: Canada, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 150: Canada, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 151: Mexico, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 152: Mexico, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 153: Mexico, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 154: South America, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 155: South America, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 156: South America, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 157: Brazil, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 158: Brazil, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 159: Brazil, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 160: Chile, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 161: Chile, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 162: Chile, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 163: Argentina, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 164: Argentina, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 165: Argentina, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 166: Colombia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 167: Colombia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 168: Colombia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 169: Peru, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 170: Peru, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 171: Peru, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 172: Middle East, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 173: Middle East, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 174: Middle East, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 175: Saudi Arabia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 176: Saudi Arabia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 177: Saudi Arabia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 178: Israel, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 179: Israel, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 180: Israel, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 181: Iran, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 182: Iran, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 183: Iran, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 184: Turkey, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 185: Turkey, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 186: Turkey, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 187: United Arab Emirates, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 188: United Arab Emirates, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 189: United Arab Emirates, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 190: Africa, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 191: Africa, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 192: Africa, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 193: Egypt, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 194: Egypt, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 195: Egypt, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 196: Nigeria, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 197: Nigeria, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 198: Nigeria, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 199: South Africa, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 200: South Africa, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 201: South Africa, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 202: Global Biologics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 203: Global Biologics Market - Company Scoring Matrix
  • Table 204: Merck & Co. Inc. Financial Performance
  • Table 205: AbbVie Inc. Financial Performance
  • Table 206: F. Hoffmann-La Roche AG Financial Performance
  • Table 207: Johnson & Johnson Financial Performance
  • Table 208: Pfizer Inc. Financial Performance
  • Table 209: Global Biologics Market, Competitive Benchmarking (In USD Billions)
  • Table 210: Global Biologics Market, Competitive Dashboard
  • Table 211: Global Biologics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 212: Global, Biologics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 213: Global, Biologics Market Size Gain ($ Billion), Segmentation By Drug Classification, 2025 – 2030
  • Table 214: Global, Biologics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Biologics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Biologics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Biologics Market, Supply Chain Analysis
  • Figure 4: Global Biologics Market, Major Raw Material Providers
  • Figure 5: Global Biologics Market, Major Resource Providers
  • Figure 6: Global Biologics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Biologics Market, Major Distributors And Channel Partners
  • Figure 8: Global Biologics Market, Key Technologies & Future Trends
  • Figure 9: Global Biologics Market, Major Trends
  • Figure 10: Global Biologics Market, Major End Users
  • Figure 11: Global Biologics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Biologics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Biologics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Biologics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Biologics Market, Sub-Segmentation Of Monoclonal Antibodies (MAbs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Biologics Market, Sub-Segmentation Of Therapeutic Proteins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Bangladesh, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Bangladesh, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Bangladesh, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Thailand, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Thailand, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Thailand, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Vietnam, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Vietnam, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Vietnam, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Malaysia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Malaysia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Malaysia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Singapore, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Singapore, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Singapore, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Philippines, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Philippines, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Philippines, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Hong Kong, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Hong Kong, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Hong Kong, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: New Zealand, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: New Zealand, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: New Zealand, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Taiwan, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Taiwan, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Taiwan, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: South East Asia , Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: South East Asia , Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: South East Asia , Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Western Europe, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Western Europe, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: Western Europe, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: UK, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: UK, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: UK, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Germany, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Germany, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Germany, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: France, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: France, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: France, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Italy, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Italy, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Italy, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Spain, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Spain, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Spain, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Austria, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Austria, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Austria, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Belgium, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Belgium, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Belgium, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 100: Denmark, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 101: Denmark, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 102: Denmark, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 103: Finland, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 104: Finland, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 105: Finland, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 106: Ireland, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 107: Ireland, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 108: Ireland, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 109: Netherlands, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 110: Netherlands, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 111: Netherlands, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 112: Norway, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 113: Norway, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 114: Norway, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 115: Portugal, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 116: Portugal, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 117: Portugal, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 118: Sweden, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 119: Sweden, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 120: Sweden, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 121: Switzerland, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 122: Switzerland, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 123: Switzerland, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 124: Eastern Europe, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 125: Eastern Europe, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 126: Eastern Europe, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 127: Russia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 128: Russia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 129: Russia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 130: Czech Republic, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 131: Czech Republic, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 132: Czech Republic, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 133: Poland, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 134: Poland, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 135: Poland, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 136: Romania, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 137: Romania, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 138: Romania, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 139: Ukraine, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 140: Ukraine, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 141: Ukraine, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 142: North America, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 143: North America, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 144: North America, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 145: USA, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 146: USA, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 147: USA, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 148: Canada, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 149: Canada, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 150: Canada, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 151: Mexico, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 152: Mexico, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 153: Mexico, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 154: South America, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 155: South America, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 156: South America, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 157: Brazil, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 158: Brazil, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 159: Brazil, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 160: Chile, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 161: Chile, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 162: Chile, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 163: Argentina, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 164: Argentina, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 165: Argentina, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 166: Colombia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 167: Colombia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 168: Colombia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 169: Peru, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 170: Peru, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 171: Peru, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 172: Middle East, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 173: Middle East, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 174: Middle East, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 175: Saudi Arabia, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 176: Saudi Arabia, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 177: Saudi Arabia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 178: Israel, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 179: Israel, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 180: Israel, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 181: Iran, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 182: Iran, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 183: Iran, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 184: Turkey, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 185: Turkey, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 186: Turkey, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 187: United Arab Emirates, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 188: United Arab Emirates, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 189: United Arab Emirates, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 190: Africa, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 191: Africa, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 192: Africa, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 193: Egypt, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 194: Egypt, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 195: Egypt, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 196: Nigeria, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 197: Nigeria, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 198: Nigeria, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 199: South Africa, Biologics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 200: South Africa, Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 201: South Africa, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 202: Global Biologics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 203: Global Biologics Market - Company Scoring Matrix
  • Figure 204: Merck & Co. Inc. Financial Performance
  • Figure 205: AbbVie Inc. Financial Performance
  • Figure 206: F. Hoffmann-La Roche AG Financial Performance
  • Figure 207: Johnson & Johnson Financial Performance
  • Figure 208: Pfizer Inc. Financial Performance
  • Figure 209: Global Biologics Market, Competitive Benchmarking (In USD Billions)
  • Figure 210: Global Biologics Market, Competitive Dashboard
  • Figure 211: Global Biologics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 212: Global, Biologics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 213: Global, Biologics Market Size Gain ($ Billion), Segmentation By Drug Classification, 2025 – 2030
  • Figure 214: Global, Biologics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Adm...

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administrat...

Frequently Asked Questions

The Biologics market was valued at $495.56 billion in 2025, increased to $540.46 billion in 2026, and is projected to reach $827.24 billion by 2030.

The global Biologics market is expected to grow at a CAGR of 11.2% from 2026 to 2035 to reach $827.24 billion by 2035.

Some Key Players in the Biologics market Include, Merck & Co. Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc., Bristol Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Amgen Inc., Shanghai Fosun Pharmaceuticals, Bayer AG, Novartis AG, BiosanaPharma, WuXi, Teva UK Limited, AstraZeneca, Abbott Laboratories, Vectura Group, Fujifilm, Lonza, Seqens, Piramal Pharma Solutions, Corden Pharma, Procos SpA and BSP Pharmaceuticals., Microgen, Geropharm, Valenta, NovaMedica, SynBi, Rani Therapeutics, Enteris BioPharma, Allena Pharmaceuticals, Biogen Inc., Emisphere Technologies Inc., Apotex, Gilead Sciences .

Major trend in this market includes: Advancing Efficiency Through Next-Generation Biomanufacturing. For further insights on this market. request a sample here

North America was the largest region in the biologics market in 2025. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us